Clinical Trial Update: A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing the fixed-dose combination Saxagliptin/metformin XR to co-administration in adults with Type 2 Diabetes Mellitus; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Kombiglyze XR (Saxagliptin/metformin XR)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus(T2DM) | Phase 1 | Status: COMPLETED